PolTREG appoints Dan Shelly as Chief Business Development Officer
Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announces today it has appointed Prof. Daniel Shelly, …